OPEN SOURCE PSYCHIATRY
  • About
  • Clinical Care
    • Lab Monitoring >
      • Antipsychotics
      • Mood Stabilizers
    • Prescribing Guidelines >
      • Depakote Loading for Mania
      • Gabapentin for Alcohol Detoxification
      • Haloperidol for Delirium
      • Tapering Benzodiazepines
      • Vivitrol for Alcohol Use Disorder
    • Useful Clinical Links >
      • Cheapest prescriptions
      • Grand Rounds >
        • ASAM
        • UCLA
        • Yale
      • Independent lab testing of supplements and herbal medications
      • Women's mental health
  • Education
    • Proof-of-Concept Protocols >
      • Anti-Inflammatory Agents
      • ARA 290 (CNS Targeted Erythropoietin)
      • Low-Dose Naltrexone
      • The Incentive Salience Hypothesis: A Novel Treatment Strategy for Depression
    • Psychopharmacology >
      • All About Lithium
      • Talmudic Psychopharmacology
    • Technology & Medicine >
      • How to Curate the Medical Literature
      • How to Use Smartphrases
    • Wellness >
      • Inspirations
      • Limbic Listening
      • Music
      • Sleep

MGH IV Haloperidol Protocol for Agitation in Delirious Patients


1) Check pre-haloperidol QTc interval
  • If QTC > 450 ms, proceed with care
  • If QTC > 500 ms, consider other options* (see  #6)

2) Check potassium and magnesium, and correct abnormalities
  • Aim for potassium > 4 mEq/L, magnesium > 2 mEq/L

3) Give dose of haloperidol (0.5-10 mg) based on level of agitation, and patient's age and size; start with 1 mg for patients who are elderly; start with 2 mg for non-elderly
  • Goal is to have patient calm and awake
  • Haloperidol precipitates with phenytoin and heparin; flush line before giving haloperidol if thee agents have been used in the IV tubing
  • Wait 20-30 minutes. If patient remains agitated, double dose.
  • Continue to double dose q 30 minutes until patient calm

4) Follow QTc interval to ensure that QTc is not prolonging
  • Obtain EKGs and check QTc prior to the second and third doses of haloperidol administered to assess for lengthening
  • If QTcs are < 450, can increase interval EKG monitoring to q 24 hrs
  • If QTc increases by 25% or becomes > 500, consider alternative treatments and monitoring frequency (see # 6)

5) Once effective dose has been determined, use that dose for future episodes of agitation
  • Depending on likely course of delirium, may schedule haloperidol or give prn (e.g. may divide previous effective dose over next 24 hrs giving q6 hrs)
  • Consider small dose at night to regulate sleep-wake cycle in all delirious patients

6) If QTc is > 500 or is increasing > 25%
  • Consider switch to Zyprexa or Abilify as they seem to be least associated with QTc prolongation
  • If continuing to use antipsychotics, follow QTc closely i.e. prior to each antipsychotic administration, monitor electrolytes closely, particularly K/Mg, and aggressively replete
  • Primary team should discuss and analyze R/B/A on an individual patient basis
  • Alternatives include temporizing measures—benzodiazapines, opioids, anticonvulsant mood stabilizers; of note, benzodiazapines and opioids may help to control and contain symptoms of delirium in the short-term but may also be associated with worsening of mental status in delirious patients

7) If QTc > 550
  • Strongly consider temporizing measures, alternatives to antipsychotics above!
  • R likely > B at this length of QTc

Sources:
Stern, T. Huffman, J. Primary Care Companion J Clin Psych, 2003
The MGH/McLean Psychiatry Residents' Handbook, 2009-2010



  • About
  • Clinical Care
    • Lab Monitoring >
      • Antipsychotics
      • Mood Stabilizers
    • Prescribing Guidelines >
      • Depakote Loading for Mania
      • Gabapentin for Alcohol Detoxification
      • Haloperidol for Delirium
      • Tapering Benzodiazepines
      • Vivitrol for Alcohol Use Disorder
    • Useful Clinical Links >
      • Cheapest prescriptions
      • Grand Rounds >
        • ASAM
        • UCLA
        • Yale
      • Independent lab testing of supplements and herbal medications
      • Women's mental health
  • Education
    • Proof-of-Concept Protocols >
      • Anti-Inflammatory Agents
      • ARA 290 (CNS Targeted Erythropoietin)
      • Low-Dose Naltrexone
      • The Incentive Salience Hypothesis: A Novel Treatment Strategy for Depression
    • Psychopharmacology >
      • All About Lithium
      • Talmudic Psychopharmacology
    • Technology & Medicine >
      • How to Curate the Medical Literature
      • How to Use Smartphrases
    • Wellness >
      • Inspirations
      • Limbic Listening
      • Music
      • Sleep